The text discusses the results of a randomized phase III trial on the use of ucovorin-modulated bolus 5-fluorouracil in adjuvant colon cancer treatment, as well as the effects of scheduled follow-up for detecting recurrence of colorectal cancer and recommendations for the therapeutic management of liver metastases in colorectal cancer. Additionally, it mentions a randomized trial comparing different adjuvant chemotherapy regimens for colorectal cancer.